Paul A Friedman Insider Trading Activity
Paul A Friedman has been net-selling over the last 12 months with 0 purchases and 66 sales across 1 company.
MDGL is the most-traded position with 66 trades. The largest single transaction was a sale of MDGL for $10.8M on Aug 13, 2025.
Performance Scorecard
Forward stock performance after each transaction by Paul A Friedman. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -5.1% | 49% | 76 |
| 90 days | — | -17.4% | 33% | 76 |
| 120 days | — | -25.0% | 49% | 76 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersMDGL · MADRIGAL PHARMACEUTICALS, INC.
🔒 Subscribe to see trade entries
Pro members see exactly when Paul A Friedman bought and sold MDGL.
Upgrade to ProRecent Trades
Showing the 50 most recent of 76 disclosed trades.
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jan 9, 2026 | MDGL | Sell | 1,996 | $515.81 | $1.0M | −1.0% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,199 | $524.10 | $628K | −0.6% | Director | |
Jan 9, 2026 | MDGL | Sell | 2,432 | $525.05 | $1.3M | −1.2% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,066 | $526.00 | $561K | −0.5% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,560 | $526.97 | $822K | −0.8% | Director | |
Jan 9, 2026 | MDGL | Sell | 575 | $528.18 | $304K | −0.3% | Director | |
Jan 9, 2026 | MDGL | Sell | 691 | $529.17 | $366K | −0.4% | Director | |
Jan 9, 2026 | MDGL | Sell | 166 | $529.76 | $88K | −0.1% | Director | |
Jan 9, 2026 | MDGL | Sell | 280 | $530.69 | $149K | −0.1% | Director | |
Jan 9, 2026 | MDGL | Sell | 80 | $532.50 | $43K | −0.0% | Director | |
Jan 9, 2026 | MDGL | Sell | 332 | $534.16 | $177K | −0.2% | Director | |
Jan 9, 2026 | MDGL | Sell | 148 | $535.29 | $79K | −0.1% | Director | |
Jan 9, 2026 | MDGL | Sell | 473 | $536.02 | $254K | −0.2% | Director | |
Jan 9, 2026 | MDGL | Sell | 487 | $536.88 | $261K | −0.3% | Director | |
Jan 9, 2026 | MDGL | Sell | 480 | $539.23 | $259K | −0.3% | Director | |
Jan 9, 2026 | MDGL | Sell | 600 | $540.36 | $324K | −0.3% | Director | |
Jan 9, 2026 | MDGL | Sell | 40 | $545.79 | $22K | −0.0% | Director | |
Jan 9, 2026 | MDGL | Sell | 280 | $551.24 | $154K | −0.1% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,094 | $513.11 | $561K | −0.5% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,345 | $514.68 | $692K | −0.6% | Director | |
Jan 9, 2026 | MDGL | Sell | 766 | $516.84 | $396K | −0.4% | Director | |
Jan 9, 2026 | MDGL | Sell | 2,450 | $517.86 | $1.3M | −1.2% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,363 | $518.68 | $707K | −0.7% | Director | |
Jan 9, 2026 | MDGL | Sell | 846 | $519.88 | $440K | −0.4% | Director | |
Jan 9, 2026 | MDGL | Sell | 681 | $521.03 | $355K | −0.3% | Director | |
Jan 9, 2026 | MDGL | Sell | 1,480 | $511.98 | $758K | −0.7% | Director | |
Jan 9, 2026 | MDGL | Sell | 840 | $521.98 | $438K | −0.4% | Director | |
Jan 9, 2026 | MDGL | Sell | 970 | $523.00 | $507K | −0.5% | Director | |
Dec 10, 2025 | MDGL | Sell | 1,029 | $555.00 | $571K | −0.5% | Director | |
Dec 10, 2025 | MDGL | Sell | 160 | $555.39 | $89K | −0.1% | Director | |
Dec 10, 2025 | MDGL | Sell | 624 | $547.75 | $342K | −0.3% | Director | |
Dec 10, 2025 | MDGL | Sell | 535 | $548.51 | $293K | −0.3% | Director | |
Dec 10, 2025 | MDGL | Sell | 409 | $549.99 | $225K | −0.2% | Director | |
Dec 10, 2025 | MDGL | Sell | 4,316 | $550.93 | $2.4M | −2.1% | Director | |
Dec 10, 2025 | MDGL | Sell | 7,193 | $551.67 | $4.0M | −3.5% | Director | |
Dec 10, 2025 | MDGL | Sell | 5,533 | $552.74 | $3.1M | −2.8% | Director | |
Dec 10, 2025 | MDGL | Sell | 5,001 | $553.83 | $2.8M | −2.6% | Director | |
Aug 13, 2025 | MDGL | Sell | 1,600 | $358.23 | $573K | −0.5% | Director | |
Aug 13, 2025 | MDGL | Sell | 4,155 | $374.38 | $1.6M | −2.2% | Director | |
Aug 13, 2025 | MDGL | Sell | 24,166 | $373.35 | $9.0M | −11.2% | Director | |
Aug 13, 2025 | MDGL | Sell | 455 | $359.31 | $163K | −0.1% | Director | |
Aug 13, 2025 | MDGL | Sell | 3,153 | $360.27 | $1.1M | −1.0% | Director | |
Aug 13, 2025 | MDGL | Sell | 2,591 | $363.08 | $941K | −0.8% | Director | |
Aug 13, 2025 | MDGL | Sell | 1,754 | $361.13 | $633K | −0.6% | Director | |
Aug 13, 2025 | MDGL | Sell | 3,529 | $364.02 | $1.3M | −1.2% | Director | |
Aug 13, 2025 | MDGL | Sell | 1,439 | $362.29 | $521K | −0.5% | Director | |
Aug 13, 2025 | MDGL | Sell | 1,716 | $365.19 | $627K | −0.6% | Director | |
Aug 13, 2025 | MDGL | Sell | 3,152 | $366.22 | $1.2M | −1.1% | Director | |
Aug 13, 2025 | MDGL | Sell | 7,119 | $367.31 | $2.6M | −2.4% | Director | |
Aug 13, 2025 | MDGL | Sell | 6,788 | $368.34 | $2.5M | −2.3% | Director |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | 76 | $101.8M |
Other insiders at MADRIGAL PHARMACEUTICALS, INC.
8 other tracked filers at MDGL.